catena-Poly[[[aqua­pyridine­zinc(II)]-μ2-3,3′-(p-phenyl­ene)diacrylato] pyridine solvate]

The title compound, {[Zn(C12H8O4)(C5H5N)(H2O)]·C5H5N}n, has been prepared by hydro­thermal reaction. The ZnII atom is six-coordinated by four carboxyl­ate O atoms of two p-phenylenediacrylate (ppda2−) ligands, one N atom of a pyridine mol­ecule and one O atom of a water mol­ecule in a distorted octa­hedral environment. The carboxyl­ate groups of the ppda2− anions are in a bridging–chelating mode, in which two O atoms chelate one Zn2+ ion. These connections result in an extended chain structure. Parallel packing of the chains forms a two-dimensional network with inter­molecular edge-to-face inter­actions. Further linkages between the layers through O—H⋯O hydrogen-bonding inter­actions result in a three-dimensional supra­molecular architecture with one-dimensional recta­nglar channels

Homogenization and growth behavior of second-phase particles in a deformed Zr-Sn-Nb-Fe-Cu-Si-O alloy

Homogeneous distribution of fine second-phase particles (SPPs) fabricated by cycles of deformation and annealing in zirconium alloys is a critical consideration for the corrosion resistance of fuel claddings. Different deformation degrees of zirconium alloys would result in distinctive microstructures, leading to a distinct growth of SPPs during subsequent annealing. Unfortunately, the homogenization and growth behavior of SPPs in deformed zirconium alloys have not been well studied. In this work, a β-quenched Zr–Sn–Nb–Fe–Cu–Si–O alloy was rolled and annealed at 580◦C or 680◦C. The morphologies, distributions, and sizes of SPPs resulting from the different processing procedures were investigated. A linear distribution of SPPs is found in the β-quenched sample. Afterward, SPPs grow and are randomly distributed during heat treatment as the deformation degree or annealing time (or temperature) increases. The homogenization and growth of SPPs are attributed to the Ostwald ripening mechanism that is governed by lattice diffusion and short-circuit diffusion. The sample with a higher deformation degree is speculated to have a larger number of defects that provide more shortcuts for the mass transfer of SPPs, thereby facilitating a homogeneous distribution of fine SPPs during annealing

Homogenization and growth behavior of second-phase particles in a deformed Zr-Sn-Nb-Fe-Cu-Si-O alloy

Homogeneous distribution of fine second-phase particles (SPPs) fabricated by cycles of deformation and annealing in zirconium alloys is a critical consideration for the corrosion resistance of fuel claddings. Different deformation degrees of zirconium alloys would result in distinctive microstructures, leading to a distinct growth of SPPs during subsequent annealing. Unfortunately, the homogenization and growth behavior of SPPs in deformed zirconium alloys have not been well studied. In this work, a β-quenched Zr–Sn–Nb–Fe–Cu–Si–O alloy was rolled and annealed at 580◦C or 680◦C. The morphologies, distributions, and sizes of SPPs resulting from the different processing procedures were investigated. A linear distribution of SPPs is found in the β-quenched sample. Afterward, SPPs grow and are randomly distributed during heat treatment as the deformation degree or annealing time (or temperature) increases. The homogenization and growth of SPPs are attributed to the Ostwald ripening mechanism that is governed by lattice diffusion and short-circuit diffusion. The sample with a higher deformation degree is speculated to have a larger number of defects that provide more shortcuts for the mass transfer of SPPs, thereby facilitating a homogeneous distribution of fine SPPs during annealing

Particle size-dependent microstructure, hardness and electrochemical corrosion behavior of atmospheric plasma sprayed nicrbsi coatings

Particle size is a critical consideration for many powder coating-related industries since it significantly influences the properties of the produced materials. However, the effect of particle size on the characteristics of plasma sprayed NiCrBSi coatings is not well understood. This work investigates the microstructures, hardness and electrochemical corrosion behavior of plasma sprayed NiCrBSi coatings synthesized using different-sized powders. All coatings mainly consist of Ni, N3B, CrB, Cr7C3 and Cr3C2 phases. The coatings produced by small particles (50–75 μm) exhibit lower porosity (2.0 ± 0.8%). Such coatings show a higher fraction (15.5 vol.%) of the amorphous phase and lower hardness (700 HV0.5) than the counterparts (8.7 vol.% and 760 HV0.5, respectively) produced by large particles (75–100 μm) with higher porosity (3.0 ± 1.6%). Meanwhile, the coatings produced from smaller particles possess a larger number of non-bonded boundaries, leading to the easier penetration of corrosive medium, as well as a higher corrosion current density (0.254 ± 0.062 μA/cm2) and a lower charge transfer resistance (0.37 ± 0.07 MΩ cm2). These distinctions are attributed to particle size-induced different melting degrees and stackings of in-flight particles during deposition

Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial

Background: Previous cluster-randomized controlled trials evaluating the impact of implementing evidence-based guidelines for nutrition therapy in critical illness do not consistently demonstrate patient benefits. A large-scale, sufficiently powered study is therefore warranted to ascertain the effects of guideline implementation on patient-centered outcomes. Methods: We conducted a multicenter, cluster-randomized, parallel-controlled trial in intensive care units (ICUs) across China. We developed an evidence-based feeding guideline. ICUs randomly allocated to the guideline group formed a local "intervention team", which actively implemented the guideline using standardized educational materials, a graphical feeding protocol, and live online education outreach meetings conducted by members of the study management committee. ICUs assigned to the control group remained unaware of the guideline content. All ICUs enrolled patients who were expected to stay in the ICU longer than seven days. The primary outcome was all-cause mortality within 28 days of enrollment. Results: Forty-eight ICUs were randomized to the guideline group and 49 to the control group. From March 2018 to July 2019, the guideline ICUs enrolled 1399 patients, and the control ICUs enrolled 1373 patients. Implementation of the guideline resulted in significantly earlier EN initiation (1.20 vs. 1.55 mean days to initiation of EN; difference − 0.40 [95% CI − 0.71 to − 0.09]; P = 0.01) and delayed PN initiation (1.29 vs. 0.80 mean days to start of PN; difference 1.06 [95% CI 0.44 to 1.67]; P = 0.001). There was no significant difference in 28-day mortality (14.2% vs. 15.2%; difference − 1.6% [95% CI − 4.3% to 1.2%]; P = 0.42) between groups. Conclusions: In this large-scale, multicenter trial, active implementation of an evidence-based feeding guideline reduced the time to commencement of EN and overall PN use but did not translate to a reduction in mortality from critical illness. Trial registration: ISRCTN, ISRCTN12233792. Registered November 20th, 2017

Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial (vol 26, 46, 2022)

BackgroundPrevious cluster-randomized controlled trials evaluating the impact of implementing evidence-based guidelines for nutrition therapy in critical illness do not consistently demonstrate patient benefits. A large-scale, sufficiently powered study is therefore warranted to ascertain the effects of guideline implementation on patient-centered outcomes.MethodsWe conducted a multicenter, cluster-randomized, parallel-controlled trial in intensive care units (ICUs) across China. We developed an evidence-based feeding guideline. ICUs randomly allocated to the guideline group formed a local "intervention team", which actively implemented the guideline using standardized educational materials, a graphical feeding protocol, and live online education outreach meetings conducted by members of the study management committee. ICUs assigned to the control group remained unaware of the guideline content. All ICUs enrolled patients who were expected to stay in the ICU longer than seven days. The primary outcome was all-cause mortality within 28 days of enrollment.ResultsForty-eight ICUs were randomized to the guideline group and 49 to the control group. From March 2018 to July 2019, the guideline ICUs enrolled 1399 patients, and the control ICUs enrolled 1373 patients. Implementation of the guideline resulted in significantly earlier EN initiation (1.20 vs. 1.55 mean days to initiation of EN; difference - 0.40 [95% CI - 0.71 to - 0.09]; P = 0.01) and delayed PN initiation (1.29 vs. 0.80 mean days to start of PN; difference 1.06 [95% CI 0.44 to 1.67]; P = 0.001). There was no significant difference in 28-day mortality (14.2% vs. 15.2%; difference - 1.6% [95% CI - 4.3% to 1.2%]; P = 0.42) between groups.ConclusionsIn this large-scale, multicenter trial, active implementation of an evidence-based feeding guideline reduced the time to commencement of EN and overall PN use but did not translate to a reduction in mortality from critical illness.Trial registrationISRCTN, ISRCTN12233792 . Registered November 20th, 2017

Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial.

BackgroundPrevious cluster-randomized controlled trials evaluating the impact of implementing evidence-based guidelines for nutrition therapy in critical illness do not consistently demonstrate patient benefits. A large-scale, sufficiently powered study is therefore warranted to ascertain the effects of guideline implementation on patient-centered outcomes.MethodsWe conducted a multicenter, cluster-randomized, parallel-controlled trial in intensive care units (ICUs) across China. We developed an evidence-based feeding guideline. ICUs randomly allocated to the guideline group formed a local "intervention team", which actively implemented the guideline using standardized educational materials, a graphical feeding protocol, and live online education outreach meetings conducted by members of the study management committee. ICUs assigned to the control group remained unaware of the guideline content. All ICUs enrolled patients who were expected to stay in the ICU longer than seven days. The primary outcome was all-cause mortality within 28 days of enrollment.ResultsForty-eight ICUs were randomized to the guideline group and 49 to the control group. From March 2018 to July 2019, the guideline ICUs enrolled 1399 patients, and the control ICUs enrolled 1373 patients. Implementation of the guideline resulted in significantly earlier EN initiation (1.20 vs. 1.55 mean days to initiation of EN; difference - 0.40 [95% CI - 0.71 to - 0.09]; P = 0.01) and delayed PN initiation (1.29 vs. 0.80 mean days to start of PN; difference 1.06 [95% CI 0.44 to 1.67]; P = 0.001). There was no significant difference in 28-day mortality (14.2% vs. 15.2%; difference - 1.6% [95% CI - 4.3% to 1.2%]; P = 0.42) between groups.ConclusionsIn this large-scale, multicenter trial, active implementation of an evidence-based feeding guideline reduced the time to commencement of EN and overall PN use but did not translate to a reduction in mortality from critical illness.Trial registrationISRCTN, ISRCTN12233792 . Registered November 20th, 2017